Article
Amyloid-β fibril disruption by C60—molecular guidance for rational drug design
1 Jan 2012
Abstract excerpt
The WHO has listed Alzheimer's disease among the major neurological disorders with an estimated 35 million people affected worldwide. Amyloid-β is mostly believed to be the causative factor in Alzheimer's disease and the severity of the disease correlates with the tendency of amyloid-β to form aggregation patterns-plaques. Lacking effective medication, the identification of any underlying mechanistic principles...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
